Advancing gene-targeted therapies for central nervous system disorders : proceedings of a workshop /

Saved in:
Bibliographic Details
Author / Creator:Bain, Lisa J., rapporteur.
Imprint:Washington, DC : The National Academies Press, [2019]
©2019
Description:1 online resource (1 PDF file (xii, 80 pages)) : color illustrations
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11997437
Hidden Bibliographic Details
Other authors / contributors:Stroud, Clare, rapporteur.
National Academies of Sciences, Engineering, and Medicine (U.S.). Forum on Neuroscience and Nervous System Disorders, issuing body.
Advancing Gene-Targeted Therapies for Central Nervous System Disorders (Workshop) (2019 : Washington, D.C.)
ISBN:9780309495851
0309495857
9780309495875
0309495873
9780309495844
0309495849
Notes:Includes bibliographical references (pages 59-64).
Online resource; title from PDF title page (viewed February 14, 2020).
Summary:"On April 23 and 24, 2019 the Forum on Neuroscience and Nervous System Disorders convened a workshop titled "Advancing Gene-Targeted Therapies for Central Nervous System Disorders" in Washington, DC. This public workshop brought together experts and key stakeholders from academia, government, industry, philanthropic foundations, and disease/patient-focused nonprofit organizations to explore approaches for advancing the development of gene-targeted therapies for central nervous system (CNS) disorders, and implications of developing these therapies. Participants explored lessons learned from both successful and unsuccessful clinical development programs; new knowledge about the genetic underpinnings of brain disorders; the current status and future potential of gene-targeted therapies for CNS disorders; challenges and potential solutions for translating preclinical findings to approved therapies; and patient and caregiver perspectives. They also discussed what will be needed to develop these therapies for common disorders such as Alzheimer's and Parkinson's disease, as well as neuropsychiatric and neurodevelopmental disorders such as schizophrenia and autism. The workshop included approaches that target both DNA and RNA, as well as gene products using viral vectors, antisense oligonucleotides, and RNA interference. This publication summarizes the presentations and discussion of the workshop"--Publisher's description.
Other form:Print version: National Academies of Sciences, Engineering, and Medicine. Advancing Gene-Targeted Therapies for Central Nervous System Disorders : Proceedings of a Workshop. Washington, D.C. : National Academies Press, ©2019 9780309495844